HealthTree Logo
search more_vert
close
person Sign In / Create Account

Patrick Hagen, MD

Director of the Multiple Myeloma and Amyloidosis Program

8 years treating Multiple Myeloma | 100 Multiple Myeloma patients treated annually

Clinical Expertise

  • Multiple Myeloma 
  • Autologous stem cell transplant and
  • Chimeric antigen t-cell receptor (CAR-T) therapy

About

 My work at Loyola University incorporates both pre-clinical and clinical research as well as direct patient care. I am passionate about working with patients to find the best treatment choice tailored to each individual. My focus is primarily on plasma cell disorders including monoclonal gammopathy of unknown significance (MGUS), smoldering myeloma, multiple myeloma, plasma cell leukemia, amyloidosis (both systemic and ATTR), light chain deposition disease, and POEMS disease. However, I see patients for all malignant hematology conditions including acute and chronic leukemia, non-hodgkin and hodgkins lymphoma, a well as MDS and aplastic anemia. In particular, I focus on the role of high dose chemotherapy and autologous or allogeneic transplant as well as cellular therapy (CAR-T) in the care of patients. Further, it is my goal that every patient be offered and ideally treated on a clinical trial in order to improve patient outcomes. I am involved in translational as well as early and late phase clinical trial development.

Location

Loyola Bernardin Cancer Center: 2160 S 1st Ave, Maywood, IL 60153, USA

Get the latest thought leadership on Multiple Myeloma delivered straight to your inbox.

Subscribe to the weekly "HealthTree Community for Multiple Myeloma Newsletter" for Multiple Myeloma news, life with Multiple Myeloma stories, Multiple Myeloma clinical trials, Multiple Myeloma 101 articles and events with Multiple Myeloma experts.

Thanks to our HealthTree Community for Multiple Myeloma Sponsors:

Johnson and Johnson
Sanofi
Pfizer
Regeneron
Adaptive
Bristol Myers Squibb

Follow Us

facebook instagram linkedin tiktok youtube